Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Clinical trial NCT02877927 · COMPLETED

Trial details

NCT number: NCT02877927
Sponsor: Paratek Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Bacterial Infections Skin Structures and Soft Tissue Infections

Start date: 2016-08-01
Primary completion: 2017-05-26
Enrollment: 735

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.